Upon completion of the activity, participants should be able to explain the circumstances – and rationale – under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar. 2. Explain the circumstances under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar